Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.8307
Nov 19 • 3:36 PM ET Dollar change+0.0235 Percentage change(2.91%)
Index
-
Market Cap
24.82M
Enterprise Value
20.54M
Income
-51.49M
Sales
0.00M
Book/sh
1.88
Cash/sh
0.14
Employees
5
IPO
Dec 18, 2003
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
0.44
P/C
5.80
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
3.64
Current Ratio
3.64
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
Yes / Yes
EPS (ttm)
-1.38
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
24.47% 29.72%
Sales past 3/5Y
- -
EPS Y/Y TTM
-5.00%
Sales Y/Y TTM
-
EPS Q/Q
491.01%
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
1.62%
Insider Trans
12.67%
Inst Own
16.93%
Inst Trans
-2.55%
ROA
-59.96%
ROE
-60.95%
ROIC
-90.82%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-16.80%
SMA50
-27.44%
SMA200
-22.27%
Trades
Shs Outstand
30.19M
Shs Float
29.40M
52W High
1.99 -58.26%
52W Low
0.69 20.60%
Volatility
10.55% 9.07%
ATR (14)
0.09
RSI (14)
35.71
Beta
0.30
Rel Volume
0.25
Avg Volume
522.99K
Volume
123,571
Perf Week
-8.40%
Perf Month
-33.01%
Perf Quarter
-16.07%
Perf Half Y
-24.48%
Perf YTD
-37.07%
Perf Year
-53.33%
Perf 3Y
-86.20%
Perf 5Y
-98.08%
Perf 10Y
-96.62%
Prev Close
0.81
Price
0.83
Change %
2.91%
Consensus
Buy
Avg. Price Target
$22.67
Implied Upside
+2,629.0%
Analysts10incl. previous ratings
Rating Distribution4 Buy · 6 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jul 23, 2024Downgrade
LLaidlaw
Buy → Hold
Mar 25, 2022Downgrade
WFC logoWWells Fargo
Overweight → Equal Weight$13 → $2+140.8%
Mar 25, 2022Downgrade
SF logoSStifel
Buy → Hold$6 → $2+140.8%
Mar 25, 2022Downgrade
JEF logoJJefferies
Buy → Hold$4 → $1+20.4%
Feb 03, 2022Initiated
JEF logoJJefferies
Buy$4+381.5%
Sep 22, 2020Initiated
AAlliance Global Partners
Buy$9+983.4%
May 29, 2020Initiated
SSunTrust
Buy$16+1,826.1%
Dec 20, 2018Initiated
HH.C. Wainwright
Buy$10+1,103.8%
Dec 20, 2018Initiated
HH.C. Wainwright
Buy
Jul 27, 2018Upgrade
SF logoSStifel
Hold → Buy$2.50 → $7+742.7%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Flynn James PDirectorNov 17 '26Buy0.7927,45021,548152,450Nov 18 04:00 PM
Flynn James PDirectorJun 24 '26Buy0.8625,00021,388125,000Jun 25 04:30 PM
Schornstein Alexander10% OwnerDec 18 '25Sale1.37690,611946,1373,674,862Dec 22 04:15 PM
Flynn James PDirectorDec 19 '25Buy1.4070,00097,699100,000Dec 22 04:00 PM
Lite Strategy, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.
CEOMr. Justin J. File CPA
Chief People OfficerMs. Anne Frese
Strategic AdvisorDr. Robert D. Mass M.D.